Discover 622 paid clinical trials in Arkansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Arkansas offers a variety of research opportunities for both healthy volunteers interested in paid clinical studies and individuals seeking trials for specific health conditions. Major research centers in Little Rock, Fayetteville, and Fort Smith are actively recruiting participants, providing access to advanced treatments and innovative medical care.
Filter
1
Filter results
Results: 622
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for
Leukemia, Myeloid, Acute
Location: Halifax, Boston MA, Lebanon NH, The Bronx NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06852222
Phase3, Recruiting
Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery
for
ColoRectal Cancer and Inflammatory Bowel Disease
Location: Little Rock AR
Sponsor: University of Arkansas
Sex: All
Age: 18+
Code: NCT02997293
Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for
Chronic Spontaneous Urticaria (CSU)
Location: Boston MA, Farmington CT, The Bronx NY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06868212
Phase3, Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, The Bronx NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06532279
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
for
Malignant Melanoma
Location: Hackensack NJ, Fairfax VA, Toronto, Brampton,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06961006
Phase2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
Pelacarsen Roll-over Extension Program
for
Atherosclerotic Cardiovascular Disease
Location: Richmond Hill NY, Summit NJ, New Brunswick NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06875973
Phase3, Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Location: The Bronx NY, New Brunswick NJ, Hershey PA,
Sponsor: UroGen Pharma Ltd.
Sex: All
Age: 18+
Code: NCT06774131
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
In Vivo Real-time Detection of Circulating Melanoma Cells
for
Melanoma
Location: Little Rock AR
Sponsor: University of Arkansas
Sex: All
Age: 18 - 70+
Code: NCT01776905
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
for
Major Depressive Disorder
Location: Boston MA, Watertown MA, Methuen MA, Worcester MA,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07076407
Phase3, Recruiting
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
for
Von Willebrand Disease (VWD)
Location: New Haven CT, Morrisville NC, Pittsburgh PA, Atlanta GA,
Sponsor: Vega Therapeutics, Inc
Sex: All
Age: 12 - 70+
Code: NCT07115004
Phase3, Recruiting
Time Restricted Feeding, Muscle, and Metabolism
for
Overweight, Obesity
Location: Fayetteville AR
Sponsor: University of Arkansas, Fayetteville
Sex: All
Age: 25 - 50
Code: NCT04949451
Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer